The metabolite was found to be negatively associated with type 2 diabetes mellitus (T2DM) in a Lebanese cohort, and chronic administration of low-dose of 4-cresol in preclinical models of T2DM resulted in reduced obesity and liver fat, improved glycemic control and enhanced insulin secretion and β-cell proliferation15. This evidence concerns the gene INS and type 2 diabetes mellitus.